Arvinas Inc

NASDAQ: ARVN
$24.97
-$0.35 (-1.4%)
Closing Price on September 18, 2024

ARVN Chart and Intraday Price

ARVN Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 3,220.37M USD
Shares Outstanding 68,084,000
Arvinas Inc is a pioneering biotech firm focused on developing innovative treatments by targeting disease-causing proteins for degradation. Utilizing its proprietary PROTAC technology, Arvinas is advancing a novel class of therapies, including potential treatments for prostate cancer and breast cancer. With ongoing clinical trials and strategic partnerships with major pharmaceutical companies, Arvinas is at the forefront of leveraging the body's natural processes to fight serious diseases. Founded in 2013, the company is headquartered in New Haven, Connecticut, marking a significant player in the biotechnology industry.

ARVN Articles

Prediction: This Pharma Stock Will Be the Best Performer the Rest of 2024
Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big expectations for Vir Biotechnology.
Trey Thoelcke
Published:

Friday’s Top Analyst Upgrades and Downgrades: Analog Devices, Autodesk, Beyond Meat, CVS Health, Dick’s Sporting Goods, Medtronic, Riot Blockchain, Tesla, Yum! Brands and More
Here are the top analysts calls for Friday, November 25.
Lee Jackson
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Apple, Citigroup, JPMorgan, Kroger, Livent, Salesforce, SunPower and More
Tuesday's top analyst upgrades and downgrades included Apple, Chipotle Mexican Grill, Citigroup, Constellation Energy, Fastenal, JPMorgan Chase, Kroger, Livent, News Corp, Prologis, Salesforce and...
Lee Jackson
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Bristol-Myers, Costco, Exxon, FedEx, Lucid, Medtronic, Micron Technology, Salesforce, Six Flags, Unity Software and More
Tuesday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Costco Wholesale, Dollar General, Exxon Mobil, FedEx, Horizon Therapeutics, Hyatt Hotels, Lucid, Medtronic, Micron...
Lee Jackson
Published:

From Bad to Worse and Then Some: Analysts Upgrade or Downgrade Domino’s, iHeartMedia, Match Group, Virgin Galactic and More
Monday’s additional top analyst upgrades and downgrades were on Domino’s, iHeartMedia, Match Group, Virgin Galactic and more.
Chris Lange
Published: